GSK
GSK·NYSE
--
--(--)
--
--(--)
GSK Filings
Filing Date
Form Description
Form Type
2026-02-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-04
GSK plc (GSK) Q4 2025 Earnings Call Transcript
Earnings Call
2026-02-04 · Earnings Call
GSK plc (GSK) Q4 2025 Earnings Call Transcript
2026-02-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2026-02-04 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-02
Form SC TO-T - Tender offer statement by Third Party
2026-02-02 ·
Form SC TO-T - Tender offer statement by Third Party
2026-01-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-20
Form SC TO-C - Written communication relating to an issuer or third party
2026-01-20 ·
Form SC TO-C - Written communication relating to an issuer or third party
2026-01-20
Form SC TO-C - Written communication relating to an issuer or third party
2026-01-20 ·
Form SC TO-C - Written communication relating to an issuer or third party
